Selective antagonism of behavioural effects of nicotine by dihydro-β-erythroidine in rats

Psychopharmacology

Volumn 129, Issue 4, 1997, Pages 390-397

  Stolerman, I P ^a   Chandler, C J ^a,b   Garcha, H S ^a   Newton, J M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b LONDON METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

Dihydro erythroidine; Drug discrimination; Locomotor activity; Nicotine; Operant behaviour

Indexed keywords

DIHYDRO BETA ERYTHROIDINE; MECAMYLAMINE; NICOTINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; COMPETITIVE INHIBITION; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; DRUG ANTAGONISM; DRUG DISCRIMINATION; DRUG MECHANISM; DRUG SELECTIVITY; FOOD; INSTRUMENTAL CONDITIONING; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT;

ANIMALS; DIHYDRO-BETA-ERYTHROIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; LOCOMOTION; MALE; NICOTINE; RATS;

EID: 0031043995     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050205     Document Type: Article

References (43)

1. Alkondon M, Albuquerque EX (1993) Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. 1. Pharmacological and functional evidence for distinct structural subtypes. J Pharmacol Exp Ther 265:1455-1473
2. 3H]-Mecamylamine binding to rat brain membranes: studies with mecamylamine and nicotine analogues. Biochem Pharmacol 40:2105-2110
3. Bowman WC, Rand MJ (1980) Textbook of pharmacology. Blackwell, Oxford, pp 17.1-17.56
4. 7 nicotinic receptor antagonist methyllycaconitine. Eur J Pharmacol 301:1-5
5. Bradley PB, Dray A (1976) Observations on the pharmacology of cholinoceptive neurons in the brain stem. Br J Pharmacol 57:599-602
6. Clarke PBS (1984) Chronic central nicotine blockade after a single administration of the bisquaternary ganglion-blocking drug chlorisondamine. Br J Pharmacol 83:527-535
7. Clarke PBS (1987) Nicotine and smoking: a perspective from animal studies. Psychopharmacology 92:135-143
8. Clarke PBS, Kumar R (1983) Characterization of the locomotor stimulant action of nicotine in tolerant rats. Br J Pharmacol 80:587-594
9. Collins AC, Evans CB, Miner LL, Marks MJ (1986) Mecamylamine blockade of nicotine responses: evidence for two brain nicotinic receptors. Pharmacol Biochem Behav 24:1767-1773
10. Corrigall WA, Coen KM, Adamson KL (1994) Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Res 653:278-284
11. 3H]dopamine release by pyridino N-substituted nicotine analogues: a new class of nicotinic antagonist. Drug Dev Res 36:91-102
12. Curzon P, Brioni JD, Decker MW (1994) Behavioral effects of nicotinic cholinergic receptor (nAChR) blockade with dihydro-β-erythroidine (DHβE) and methyllycaconitine (MLA). Soc Neurosci Abstr 20:150
13. Damaj MI, Welch SP, Martin BR (1995) In vivo pharmacological effects of dihydro-β-erythroidine, a nicotinic antagonist, in mice. Psychopharmacology 117:67-73
14. Decker MW, Anderson DJ, Brioni JD, Donnelly-Roberts DL, Kang CH, O'Neill AB, Piattoni-Kaplan M, Swanson S, Sullivan JP (1995a) Erysodine, a competitive antagonist at neuronal nicotinic acetylcholine receptors. Eur J Pharmacol 280:79-89
15. Decker MW, Brioni JD, Bannon AW, Arneric SP (1995b) Diversity of neuronal nicotinic acetylcholine receptors: lessons from behaviour and implications for CNS therapeutics. Life Sci 56:545-570
16. Deneris ES, Connolly J, Rogers SW, Duvoisin R (1991) Pharmacological and functional diversity of neuronal nicotinic acetylcholine receptors. Trends Pharmacol Sci 12:34-40
17. Galzi J-L, Changeux J-P (1995) Neuronal nicotinic receptors: molecular organization and regulations. Neuropharmacology 34:563-582
18. Garcha HS, Stolerman IP (1993) Discriminative stimulus effects of the nicotine antagonist mecamylamine in rats. J Psychopharmacol 7:43-51
19. Garcha HS, Koek W, Stolerman IP (1992) Behavioural studies on the putative antagonist action of mecamylamine at NMDA receptors. J Psychopharmacol (Abstract Book): A62
20. 3H]dopamine release from synaptosomes prepared from mouse striatum. J Neurochem 59:848-856
21. Granon S, Poucet B, Thinus-Blanc C, Changeux J-P, Vidal C (1995) Nicotinic and muscarinic receptors in the rat prefrontal cortex: differential roles in working memory, response selection and effortful processing. Psychopharmacology 119:139-144
22. Harvey SC, Luetje CW (1996) Determinants of competitive antagonist sensitivity on neuronal nicotinic receptor β subunits. J Neurosci 16:3798-3806
23. Harvey SC, Maddox FN, Luetje CW (1996) Multiple determinants of dihydro-β-erythroidine sensitivity on rat neuronal nicotinic receptor α subunits. J Neurochem (in press)
24. Henningfield JE, Goldberg SR (1985) Stimulus properties of nicotine in animals and human volunteers: a review. In: Seiden LS, Balster RL (eds) Behavioral pharmacology: the current status. Liss, New York, pp 433-449
25. Khan IM, Taylor P, Yaksh TL (1994) Cardiovascular and behavioral responses to nicotinic agents administered intrathecally. J Pharmacol Exp Ther 270:150-158
26. Lingle C (1983) Blockade of cholinergic channels by chlorisondamine on a crustacean muscle. J Physiol 339:395-417
27. Luetje CW, Patrick JW (1989) Members of the neuronal nicotinic acetylcholine receptor family display distinct pharmacological and toxicological properties. Soc Neurosci Abstr 15:677
28. Mansbach RS, Rovetti CC (1996) Dopaminergic mechanisms in the discriminative stimulus effects of nicotine. In: Harris LS (ed) Problems of drug dependence 1995. NIDA Monograph, National Institute on Drug Abuse, Rockville, Maryland (in press)
29. Martin BR, Onaivi ES, Martin TJ (1989) What is the nature of mecamylamine's antagonism of nicotine's central effects by mecamylamine and pempidine? Biochem Pharmacol 38: 3391-3397
30. Martin TJ, Suchocki J, May EL, Martin BR (1990) Pharmacological evaluation of the antagonism of nicotine's central effects by mecamylamine and pempidine. J Pharmacol Exp Ther 254: 45-51
31. O'Dell TJ, Christensen BN (1988) Mecamylamine is a selective non-competitive antagonist of N-methyl-D-aspartate- and aspartate-induced currents in horizontal cells dissociated from catfish retina. Neurosci Lett 94:93-98
32. 3H](-)-nicotine to rat brain membranes and its inhibition by analogues of nicotine. Neuropharmacology 27:235-241
33. Reavill C, Waters JA, Stolerman IP, Garcha HS (1990) Behavioural effects of the nicotinic agonists N-(3-pyridylmethyl)pyrrolidine and isoarecolone in rats. Psychopharmacology 102:521-528
34. Romano C, Goldstein A, Jewell NP (1981) Characterization of the receptor mediating the nicotine discriminative stimulus. Psychopharmacology 74:310-315
35. Spealman RD, Goldberg SR (1982) Maintenance of schedule-controlled behavior by intravenous injections of nicotine in squirrel monkeys. J Pharmacol Exp Ther 223:402-408
36. Spealman RD, Goldberg SR, Gardner ML (1981) Behavioral effects of nicotine: schedule-controlled responding by squirrel monkeys. J Pharmacol Exp Ther 216:484-491
37. Stolerman IP (1990) Behavioural pharmacology of nicotine in animals. In: Wonnacott S, Russell MAH, Stolerman IP (eds) Nicotine psychopharmacology: molecular, cellular and behavioural aspects. Oxford Science Publications, Oxford, pp 278-306
38. Stolerman IP, D'Mello GD (1981) Role of training conditions in discrimination of central nervous system stimulants by rats. Psychopharmacology 73:295-303
39. Stolerman IP, Reavill C (1989) Primary cholinergic and indirect dopaminergic mediation of behavioural effects of nicotine. Prog Brain Res 79:227-237
40. Stolerman IP, Pratt JA, Garcha HS, Giardini V, Kumar R (1983) Nicotine cue in rats analysed with drugs acting on cholinergic and 5-hydroxytryptamine mechanisms. Neuropharmacology 22:1029-1037
41. Stolerman IP, Garcha HS, Pratt JA, Kumar R (1984) Role of training dose in discrimination of nicotine and related compounds by rats. Psychopharmacology 84:413-419
42. Varanda WA, Aracava Y, Sherby SM, VanMeter WG, Eldefrawi ME, Albuquerque EX (1985) The acetylcholine receptor of the neuromuscular junction recognizes mecamylamine as a non-competitive antagonist. Mol Pharmacol 28:128-137
43. Williams M, Robinson JL (1984) Binding of the nicotinic cholinergic antagonist, dihydro-β-erythroidine, to rat brain tissue. J Neurosci 4:2906-2911